semaglutide and cardiovascular reduces heart failure risk in type 2 diabetes patients semaglutide cardiovascular trial Wegovy shown

We also collected potentially influential factors derived from physical examinations, including systolic blood pressure and body mass index (BMI)

Developing a discontinuation plan should include establishing baseline measurements (weight, waist circumference, metabolic parameters), setting realistic expectations about weight maintenance challenges, creating a detailed lifestyle modification plan with specific, measurable goals, scheduling regular follow-up appointments (initially monthly, then quarterly), identifying triggers for earlier intervention if weight regain occurs, and discussing alternative pharmacological options if needed

This can make therapies that stimulate GH sound pretty enticing

For patients, it represents the first targeted pharmacologic therapy for a disease that affects millions but has long lacked options